drug
dimethyl fumarate DR
Marketedupdated 3mo agoby SOLA Pharmaceuticals Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying dimethyl fumarate DR
- —A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
- phase3A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)
- phase3Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
- —A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)
- phase4A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)
- —Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- phase3Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)
- phase4A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 7, 2028
~1.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (18)
- Nov 16, 2035method-of-use (U-1384)US 10959972
- Nov 16, 2035method-of-use (U-1384)US 10959972
- Nov 16, 2035method-of-use (U-1384)US 11007166
- Nov 16, 2035method-of-use (U-1384)US 11007166
- Nov 16, 2035method-of-use (U-1384)US 11007167
- Nov 16, 2035method-of-use (U-1384)US 11007167
- Nov 16, 2035method-of-use (U-1384)US 11129806
- Nov 16, 2035method-of-use (U-1384)US 11129806
- Nov 16, 2035method-of-use (U-1384)US 11246850
- Nov 16, 2035method-of-use (U-1384)US 11246850
- Mar 13, 2035method-of-use (U-3148)US 10391160
- Mar 13, 2035method-of-use (U-3148)US 10391160
- Mar 13, 2035method-of-use (U-3148)US 10555993
- Mar 13, 2035method-of-use (U-3148)US 10555993
- Mar 13, 2035method-of-use (U-3148)US 10994003
- Mar 13, 2035method-of-use (U-3148)US 10994003
- Feb 7, 2028method-of-use (U-1384)US 83995141.5y
- Feb 7, 2028method-of-use (U-1384)US 83995141.5y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 29m ago
Found something off?
comments(0)
5-min edit window · permanent after that